GRIPT: a novel case-control analysis method for Mendelian disease gene discovery

Genome Biol. 2018 Nov 26;19(1):203. doi: 10.1186/s13059-018-1579-x.


Despite rapid progress of next-generation sequencing (NGS) technologies, the disease-causing genes underpinning about half of all Mendelian diseases remain elusive. One main challenge is the high genetic heterogeneity of Mendelian diseases in which similar phenotypes are caused by different genes and each gene only accounts for a small proportion of the patients. To overcome this gap, we developed a novel method, the Gene Ranking, Identification and Prediction Tool (GRIPT), for performing case-control analysis of NGS data. Analyses of simulated and real datasets show that GRIPT is well-powered for disease gene discovery, especially for diseases with high locus heterogeneity.

Keywords: Cohort analysis; Disease gene prioritization; Locus heterogeneity; Mendelian disease; Next-generation sequencing.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Computer Simulation
  • Genetic Association Studies / methods*
  • Genetic Diseases, Inborn / genetics*
  • Humans
  • Inheritance Patterns
  • Sensitivity and Specificity